Feinstein Institutes Breakthrough: Bioelectronic Medicine Accelerates Blood Clotting via Vagus Nerve Stimulation — The Feinstein Institutes for Medical Research

Event summary

Feinstein Institutes scientists demonstrated that wearable ear devices activating the vagus nerve can accelerate blood clotting in humans.
The study, published July 13, 2026 in Bioelectronic Medicine, used Spark Biomedical’s transcutaneous auricular neurostimulation (tAN®) platform.
Both taVNS and tAN® modalities successfully increased platelet function without adverse events or systemic hypercoagulability.
Research builds on prior animal studies showing 75% reduction in blood loss via vagus nerve stimulation.

The big picture

This discovery positions Feinstein Institutes as a leader in bioelectronic medicine, expanding applications beyond inflammation to hemorrhage control. The non-invasive approach could disrupt $3B+ global hemostasis market by offering portable alternatives to tourniquets and clotting agents. Success hinges on demonstrating efficacy across diverse bleeding scenarios.

What we're watching

Clinical Translation: How quickly Feinstein Institutes can advance from mechanistic studies to human trials for specific bleeding conditions.
Commercialization Path: Whether Spark Biomedical’s tAN® platform can be adapted into a deployable medical device within 24 months.
Competitive Positioning: The pace at which bioelectronic approaches challenge traditional hemostatic agents in trauma and surgical care markets.